Ergoteles’s Calavo Growers CVGW Stock Holding History

Ergoteles’s Portfolio CVGW Stock Details CVGW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-18,500	Closed	-$532K	–	1126
2023 Q1	$532K	Buy	+18,500	New	+$555K	0.02%	710
2021 Q4	–	Sell	-14,890	Closed	-$569K	–	1301
2021 Q3	$569K	Buy	+14,890	New	+$744K	0.02%	529

Other funds holding CVGW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $588M AUM 6.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Ergoteles's CVGW Position: Q2 2023 in Review

Ergoteles sold out of Calavo Growers (CVGW) in Q2 2023, closing a stake of 18,500 shares — an estimated $532K sold.

Ergoteles first reported a position in CVGW in Q3 2021 and held it in 2 quarters. The position peaked at $569K in Q3 2021. 148 funds tracked by Wall St. Rank hold CVGW as of Q2 2023.

Ergoteles reported no remaining Calavo Growers position as of Q2 2023 after selling out during the quarter.
Ergoteles sold 18,500 Calavo Growers shares in Q2 2023, an estimated $532K.
Ergoteles first reported a position in Calavo Growers in Q3 2021 and held it in 2 quarters.
Ergoteles's Calavo Growers position peaked at $569K in Q3 2021.
148 funds tracked by Wall St. Rank held Calavo Growers as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.